The Kaplan-Meier survival analysis displayed that increased expression of YTHDF2 is significantly correlated with worse overall survival (OS) in ovarian cancer (Fig. 4e, P = 0.0013), which is in line with the result from the TCGA ovarian cancer cohort (Supplementary Fig. 5B). This evidence concerns the gene YTHDF2 and ovarian carcinoma.